Parkinson's Disease as a Risk Factor for Prostate Adenocarcinoma: a Molecular Point of View
Conclusion: Bioinformatics was used to identify potential targets and novel molecular mechanisms that may serve as clinical markers for the diagnosis and treatment of PD and PRAD.
Source: Gerontology - Category: Geriatrics Source Type: research
More News: Acetaminophen | Adenocarcinoma | Brain | Cancer | Cancer & Oncology | Databases & Libraries | Epidemiology | Genetics | Geriatrics | Lortab | Molecular Biology | Neurology | Parkinson's Disease | Study